Insulin - producing cells derived from stem cells: Recent progress and future directions

Journal of Cellular and Molecular Medicine

Volumn 10, Issue 4, 2006, Pages 852-868

  Santana, A ^a   Ensenat Waser R ^b   Arribas, Maria Isabel ^c   Reig, J A ^c   Roche, E ^c  

^a Childhood Hospital of Canary Islands   (Spain)

^b RWTH AACHEN UNIVERSITY   (Germany)

^c MIGUEL HERNÁNDEZ UNIVERSITY   (Spain)

Author keywords

cells; Adult stem cells; Cell therapy; Diabetes; Embryonic stem cells

Indexed keywords

ANIMALIA;

EID: 84867224463     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.2755/jcmm010.004.06     Document Type: Article

References (107)

1. Zimmet P, Alberti KGMM, Shaw J. Global and societal implications of the diabetes epidemic. Nature 2001; 414: 782-7.
2. th ed. Chichester (UK): John Wiley and Sons; 2004.
3. Roche E, Reig JA, Campos A, Paredes B, Isaac JR, Lim S, Calne RY, Soria B. Insulin-secreting cells derived from stem cells: Clinical perspectives, hypes and hopes. Transplant Immunol. 2005; 15: 113-29.
4. Ryan EA, Paty BW, Senior PA, Bigam D, Alfadhli E, Kneteman NM, Lakey JR, Shapiro AM. Five-year follow-up after clinical islet transplantation. Diabetes 2005; 54: 2060-9.
5. Roche E, Santana A, Vicente-salar N, Reig JA. From stem cells to insulin-producing cells: towards a bioartificial endocrine pancreas. Panminerva Med. 2005; 47: 39-51.
6. Shapiro AM, Lakey JR, Ryan EA, Korbutt GS, Toth E, Warnock GL, Kneteman NM, Rajotte RV. N Engl J Med. 2000; 343: 230-8.
7. Prentki M. New insights into pancreatic β-cell metabolic signaling in insulin secretion. Eur J Endocrinol. 1996; 134: 272-86.
8. Rolland F, Winderickx J, Thevelein JM. Glucose-sensing mechanisms in eukaryotic cells. TRENDS Biochem Sci. 2001; 26: 310-7.
9. Henquin J-C. Triggering and amplifying pathways of regulation of insulin secretion by glucose. Diabetes 2000; 49:1751-60.
10. 2+ channels in pancreatic β cells. Proc Natl Acad Sci USA. 1999; 96: 10164-9.
11. Smith AG. Embryo-derived stem cells: of mice and men. Annu Rev Cell Dev Biol. 2001; 17: 435-62.
12. Kubo A, Shinozaki K, Shannon JM, Kouskoff, Kennedy M, Woo S, Fehling HJ, Keller G. Development of definitive endoderm from embryonic stem cells in culture. Development 2004; 131: 1651-62.
13. Soria B, Skoudy A, Martin F. From stem cells to betacells: New strategies in cell therapy of diabetes mellitus. Diabetologia 2001; 44: 407-15.
14. Roche E, Burcin MM, Esser S, Rüdiger M, Soria B. The use of gating technology in bioengineering insulin-secreting cells from embryonic stem cells. Cytotechnology 2003; 41: 145-51.
15. Soria B, Roche E, Berna G, Leon-Quinto T, Reig JA, Martin F. Insulin-secreting cells derived from embryonic stem cells normalize glycemia in streptozotocin-induced diabetic mice. Diabetes 2000; 49: 157-62.
16. Chakrabarti SK, Mirmira RG. Transcription factors direct the development and function of pancreatic β cells. Trends Endocrinol Metab. 2003; 14: 78-84.
17. Nir T, Dor Y. How to make pancreatic β cells - prospects for cell therapy in diabetes. Curr Op Biotechnol. 2005; 16:524-9.
18. Roche E, Sepulcre P, Reig JA, Santana A, Soria B. Ectodermal commitment of insulin-producing cells derived from mouse embryonic stem cells. FASEB J. 2005; 19: 1341-3.
19. Hernandez-Sanchez C, Mansilla A, de la Rosa EJ, de Pablo F. Proinsulin in development: new roles for an ancient prohormone. Diabetologia 2006; 49: 1142-50.
20. Lumelsky N, Blondel O, Laeng P, Velasco I, Ravin R, McKay R. Differentiation of embryonic stem cells to insulin-secreting structures similar to pancreatic islets. Science 2001; 292: 1389-94.
21. Zulewski H, Abraham EJ, Gerlach MJ, Daniel PB, Moritz W, Muller B, Vallejo M, Thomas MK, Habener JF. Multipotential nestin-positive stem cells isolated from adult pancreatic islets differentiate ex vivo into pancreatic endocrine, exocrine and hepatic phenotypes. Diabetes 2001; 50: 521-33.
22. Abraham EJ, Leech CA, Lin JC, Zulewski H, Habener JF. Insulinotropic hormone glucagon-like peptide-1 differentiation of human pancreatic islet-derived progenitor cells into insulin-producing cells. Endocrinology 2002; 143: 3152-61.
23. Hori Y, Rulifson IC, Tsai BC, Heit JJ, Cahoy JD, Kim SK. Growth inhibitors promote differentiation of insulinproducing tissue from embryonic stem cells. Proc Natl Acad Sci USA. 2002; 99: 16105-10.
24. Hansson M, Tonning A, Frandsen U, Petri A, Rajagopal J, Englund MC, Heller RS, Hakansson J, Fleckner J, Skold HN, Melton D, Semb H, Serup P. Artifactual insulin release from differentiated embryonic stem cells. Diabetes 2004; 53: 2603-9.
25. Moritoh Y, Yamato E, Yasui Y, Miyazaki S, Miyazaki J. Analysis of insulin-producing cells during in vitro differentiation from feeder-free embryonic stem cells. Diabetes 2003; 52: 1163-8.
26. Miyazaki S, Yamato E, Miyazaki J. Regulated expression of Pdx1 promotes in vitro differentiation of insulinproducing cells from embryonic stem cells. Diabetes 2004; 53: 1030-7.
27. McKinnon CM, Docherty K. Pancreatic duodenal homeobox-1, PDX-1, a major regulator of beta cell identity and function. Diabetologia 2001; 44: 1203-14.
28. Perez-Villamil B, Schwartz PT, Vallejo M. The pancreatic homeodomain transcription factor IDX1/IPF1 is expressed in neural cells during brain development. Endocrinology 1999; 140: 3857-60.
29. Blyszczuk P, Czyz J, Kania G, Wagner M, Roll U, St-Onge L, Wobus AM. Expression of Pax4 in embryonic stem cells promotes differentiation of nestin-positive progenitor and insulin-producing cells. Proc Natl Acad Sci USA. 2003; 100: 998-1003.
30. Sipione S, Eshpeter A, Lyon JG, Korbutt GS, Bleackley RC. Insulin expressing cells from differentiated embryonic stem cells are not beta cells. Diabetologia 2004; 47: 499-508.
31. Li M, Pevny L, Lovell-Badge R, Smith A. Generation of purified neural precursors from embryonic stem cells by lineage selection. Curr Biol. 1998; 8: 971-4.
32. Hori Y, Gu X, Xie X, Kim SK. Differentiation of insulinproducing cells from human neural progenitor cells. PLoS Medicine 2005; 2: 347-56.
33. Kania G, Blyszczuk P, Wobus AM. The generation of insulin-producing cells from embryonic stem cells - a discussion of controversial findings. Int J Dev Biol. 2004; 48: 1061-4.
34. Blyszczuk P, Asbrand C, Rozzo A, Kania G, St-Onge L, Rupnik M, Wobus AM. Embryonic stem cells differentiate into insulin-producing cells without selection of nestin-expressing cells. Int J Dev Biol. 2004; 48: 1095-104.
35. Leon-Quinto T, Jones J, Skoudy A, Burcin M, Soria B. In vitro directed differentiation of mouse embryonic stem cells into insulin-producing cells. Diabetologia 2004; 47: 1442-51.
36. Vaca P, Martin F, Vegara-Meseguer JM, Rovira JM, Berna G, Soria B. Induction of differentiation of embryonic stem cells into insulin secreting cells by fetal soluble factors. Stem Cells 2006; 24: 258-65.
37. Ku HT, Zhang N, Kubo A, O'Connor R, Mao M, Keller G, Bromberg JS. Committing embryonic stem cells to early endocrine pancreas in vitro. Stem Cells. 2004; 22: 1205-17.
38. Bai I, Meredith G, Tuch BE. Glucagon-like peptide-1 enhances production of insulin in insulin-producing cells derived from mouse embryonic stem cells. J Endocrinol. 2005; 186: 343-52.
39. Lester LB, Kuo HC, Andrews L, Nauert B, Wolf DP. Directed differentiation of rhesus monkey ES cells into pancreatic cell phenotypes. Reprod Biol Endocrinol. 2004; 2: 42.
40. Stafford D, Prince VE. Retinoic acid signaling is required for a critical early step in zebrafish pancreatic development. Curr Biol. 2002; 12: 1215-20.
41. Micallef SJ, Janes ME, Knezevic K, Davis RP, Elefanty AG, Stanley EG. Retinoic acid induces Pdx1-positive endoderm in differentiating mouse embryonic stem cells. Diabetes 2005; 54: 301-5.
42. Shi Y, Hou L, Tang F, Jiang W, Wang P, Ding M, Deng H. Inducing embryonic stem cells to differentiate into pancreatic β cells by a novel three-step approach with activin A and all-trans retinoic acid. Stem Cells. 2005; 23: 656-62.
43. Skoudy A, Rovira M, Savatier P, Martin F, Leon-Quinto T, Soria B, Real FX. Transforming growth factor (TGF)beta, fibroblast growth factor (FGF) and retinoid signaling pathways promote pancreatic exocrine gene expression in mouse embryonic stem cells. Biochem J. 2004; 379: 749-56.
44. Segev H, Fishman B, Ziskind A, Shulman M, Itskovitz-Eldor J. Differentiation of human embryonic stem cells into insulin-producing clusters. Stem Cells. 2004; 22: 265-74.
45. Burns CJ, Minger SL, Hall S, Milne H, Ramracheya RD, Evans ND, Persaud SJ, Jones PM. The in vitro differentiation of rat neural stem cells into an insulin-expressing phenotype. Biochem Biophys Res Commun. 2005; 326: 570-7.
46. Treutelaar MK, Skidmore JM, Dias-Leme CL, Hara M, Zhang L, Simeone D, Martin DM, Burant CF. Nestin-lineage cells contribute to the microvasculature but not endocrine cells of the islet. Diabetes 2003; 52: 2503-12.
47. Selander L, Edlund H. Nestin is expressed in mesenchymal and not epithelial cells of the developing mouse pancreas. Mech Dev. 2002; 113: 189-92.
48. Lardon J, Rooman I, Bouwens L. Nestin expression in pancreatic stellate cells and angiogenic endothelial cells. Histochem Cell Biol. 2002; 117: 535-40.
49. Ta M, Choi Y, Atouf F, Park CH, Lumelsky N. The defined combination of growth factors ontrols generation of long-term replicating islet progenitor-like cells from cultures of adult mouse pancreas. Stem Cells. 2006; doi: 10.1634.
50. Ianus A, Holz GG, Theise ND, Hussain MA. In vivo derivation of glucose-competent pancreatic endocrine cells from bone marrow without evidence of cell fusion. J Clin Invest. 2003; 111: 843-50.
51. Choi JB, Uchino H, Azuma K, Iwashita N, Tanaka Y, Mochizuki H, Migita M, Shimada T, Kawamori R, Watada H. Little evidence of transdifferentiation of bone marrow-derived cells into pancreatic beta cells. Diabetologia 2003; 46: 1366-74.
52. Lechner A, Yang Y-G, Blacken RA, Wang L, Nolan AL, Habener JF. No evidence for significant transdifferentiation of bone marrow into pancreatic β-cells in vivo. Diabetes 2004; 53: 616-23.
53. Hess D, Li L, Martin M, Sakano S, Hill D, Strutt B, Thyssen S, Gray DA, Bhatia M. Bone marrow-derived stem cells initiate pancreatic regeneration. Nat Biotechnol. 2003; 21: 763-70.
54. Li FX, Zhu JW, Tessem JS, Beilke J, Varella-Garcia M, Jensen J, Hogan CJ, De Gregori J. The development of diabetes in E2f1/E2f2 mutant mice reveals important roles for bone marrow-derived cells in preventing islet cell loss. Proc Natl Acad Sci USA. 2003; 100: 12935-40.
55. Banerjee M, Kumar A, Bhonde RR. Reversal of experimental diabtes by multiple bone marrow transplantation. Biochem Biophys Res Commun. 2005; 328: 318-25.
56. Mathews V, Hanson PT, Ford E, Fujita J, Polonsky KS, Graubert TA. Recruitment of bone marrow-derived endothelial cells to sites of pancreatic beta-cell injury. Diabetes 2004: 53; 91-8.
57. Chen LB, Jiang XB, Yang L. Differentiation of rat marrow mesenchymal stem cells into pancreatic islet betacells. World J Gastroenterol. 2004; 10: 3016-20.
58. Timper K, Seboek D, Eberhardt M, Linscheid P, Christ-Crain M, Keller U, Müller B, Zulewski H. Human adipose tissue-derived mesenchymal stem cells differentiate into insulin, somatostatin, and glucagon expressing cells. Biochem Biophys Res Commun. 2006; 341: 1135-40.
59. Moriscot C, De Fraipont F, Richard M-J, Marchand M, Savatier P, Bosco D, Favrot M, Benhamou P-Y. Human bone marrow mesenchymal stem cells can express insulin and key transcription factors of the endocrine pancreas developmental pathway upon genetic and/or microenvironmental manipulation in vitro. Stem Cells. 2005; 23: 594-604.
60. Ruhnke M, Ungefroren H, Nussler A, Martin F, Brulport M, Schorman W, Hengstler JG, Klapper W, Ulrichs K, Hutchinson JA, Soria B, Parwaresch RM, Heeckt P, Kremer B, Fündrich F. Differentiation of in vitro-modified human peripheral blood monocytes into hepatocyte-like and pancreatic islet-like cells. Gastroenterology 2005; 128: 1774-86.
61. Hammerman MR. Growing new endocrine pancreas in situ. Clin Exp Nephrol. 2006; 10: 1-7.
62. Podolsky DK. Regulation of intestinal epithelial proliferation: a few answers, many questions. Am J Physiol (Gastrointest Liver Physiol 27). 1993; 264: G179-86.
63. Schuit F C, Huypens P, Heimberg H, Pipeleers DG. Glucose sensing in pancreatic beta-cells: a model for the study of other glucose-regulated cells in gut, pancreas, and hypothalamus. Diabetes 2001; 50: 1-11.
64. Kojima H, Nakamura T, Fujita Y, Kishi A, Fujimiya M, Yamada S, Kudo M, Nishio Y, Maegawa H, Haneda M, Yasuda H, Kojima I, Seno M, Wong NC, Kikkawa R, Kashiwagi A. Combined expression of pancreatic duodenal homeobox 1 and islet factor 1 induces immature enterocytes to produce insulin. Diabetes 2002; 51: 1398-408.
65. Yoshida S, Kajimoto Y, Yasuda T, Watada H, Fujitani Y, Kosaka H, Gotow T, Miyatsuka T, Umayahara Y, Yamasaki Y, Hori M. PDX-1 induces differentiation of intestinal epithelioid IEC-6 into insulin-producing cells. Diabetes 2002; 51: 2505-13.
66. Ferber S, Halkin A, Cohen H, Ber I, Einav Y, Goldberg I, Barshack I, Seijffers R, Kopolovic J, Kaiser N, Karasik A. Pancreatic and duodenal homeobox gene 1 induces expression of insulin genes in liver and ameliorates streptozotocin-induced hyperglycemia. Nat Med. 2000; 6: 568-72.
67. Kojima H, Fujimiya M, Matsumura K, Younan P, Imaeda H, Maeda M, Chan L. NeuroD-betacellulin gene therapy induces islet neogenesis in the liver and reverses diabetes in mice. Nat Med. 2003; 9: 596-603.
68. Ramiya VK, Maraist M, Arfors KE, Schatz DA, Peck AB, Cornelius JG. Reversal of insulin-dependent diabetes using islets generated in vitro from pancreatic stem cells. Nat Med. 2000; 6: 278-82.
69. Bonner-Weir S, Taneja M, Weir GC, Tatarkiewicz K, Song KH, Sharma A, O'Neil JJ. In vitro cultivation of human islets from expanded ductal tissue. Proc Natl Acad Sci USA. 2000; 97: 7999-8004.
70. Dor Y, Brown J, Martinez OI, Melton DA. Adult pancreatic β-cells are formed by self-duplication rather than stem-cell differentiation. Nature 2004; 429: 41-6.
71. Gershengorn MC, Hardikar AA, Wei C, Geras-Raaka E, Marcus-Samuels B, Raaka BM. Epithelial-to-mesenchymal transition generates proliferative human islet precursor cells. Science 2004; 306: 2261-4.
72. Bonner-Weir S, Sharma A. Are there pancreatic progenitor cells from which new islets form after birth Nat Clin Prac Endocrinol Metab. 2006; 2: 240-1.
73. Atkinson MA, Rhodes CJ. Pancreatic regeneration in type 1 diabetes: dreams on a deserted islet Diabetologia 2005; 48: 2200-2.
74. Kodama S, Kuhtreiber W, Fujimura S, Dale EA, Faustman DL. Islet regeneration during the reversal of autoimmune diabetes in NOD mice. Science 2003; 302: 1223-7.
75. Suri A, Calderon B, Esparza TJ, Frederick K, Bittner P, Unanue ER. Immunological reversal of autoimmune diabetes without hematopoietic replacement of beta cells. Science 2006; 311: 1778-80.
76. Nishio J, Gaglia JL, Turvey SE, Campbell C, Benoist C, Mathis D. Islet recovery and reversal of murine type 1 diabetes in the absence of any infused spleen cell contribution. Science 2006; 311: 1775-8.
77. Chong AS, Shen J, Tao J, Yin D, Kuznetsov A, Hara M, Philipson LH. Reversal of diabetes in non-obese diabetic mice without spleen cell-derived beta cell regeneration. Science 2006; 311: 1774-5.
78. Yang Z, Chen M, Carter JD, Nunemaker CS, Garmey JC, Kimble SD, Nadler JL. Combined treatment with lisofylline and exendin-4 reverses autoimmune diabetes. Biochem Biophys Res Commun. 2006; 344: 1017-22.
79. Seaberg RM, Smukler SR, Kieffer TJ, Enikolopov G, Asghar Z, Wheeler MB, Korbutt G, Van der Kooy D. Clonal identification of multipotent precursors from adult mouse pancreas that generate neural and pancreatic lineages. Nat Biotechnol. 2004; 22: 1115-24.
80. Baeyens L. De Breuck S, Lardon J, Mfopou JK, Rooman I, Bouwens L. In vitro generation of insulin-producing beta cells from adult exocrine cells. Diabetologia 2005; 48: 49-57.
81. Ensenat-Waser R, Santana A, Vicnete-Salar N, Cigudosa JC, Roche E, Soria B, Reig JA. Isolation and characterization of residual undifferentiated mouse embryonic stem cells from embryoid body cultures by fluorescence tracking. In Vitro Cell Dev Biol-Animal. 2006; 42: 115-23.
82. Draper JS, Smith K, Gokhale P, Moore HD, Maltby E, Johnson J, Meisner L, Zwaka TP, Thomson JA, Andrews PW. Recurrent gain of chromosomes 17q and 12 in cultured human embryonic stem cells. Nat Biotechnol. 2004; 22: 53.
83. Ward IM, Reina-San-Martin B, Olaru A, Minn K, Tamada K, Lau JS, Cascalho M, Chen L, Nussenzweig A, Livak F, Nussenzweig MC, Chen J. 53BP1 is required for class switch recombination. J Cell Biol. 2004; 165: 459-64.
84. Gellert M. V(D)J recombination: RAG proteins, repair factors, and regulation. Annu Rev Biochem. 2002; 71: 101-32.
85. Levens DL. Reconstructing MYC. Genes & Develop. 2003; 17: 1071-7.
86. Secombe J, Pierce SB, Eisenman RN. Myc: A weapon of mass destruction. Cell 2004; 117: 153-6.
87. Laybutt DR, Weir GC, Kaneto H, Lebet J, Palmiter RD, Sharma A, Bonner-Weir S. Overexpression of c-Myc in β-cells of transgenic mice causes proliferation and apoptosis, downregulation of insulin gene expression, and diabetes. Diabetes 2002; 51: 1793-804.
88. Sears RC. The life cycle of c-Myc. Cell Cycle. 2004; 3: 1133-7.
89. Murphy MJ, Wilson A, Trumpp A. More than just proliferation: Myc function in stem cells. TRENDS Cell Biol. 2005; 15: 128-37.
90. Rubio D, Garcia-Castro J, Martin MC, de la Fuente R, Cigudosa JC, Lloyd AC, Bernad A. Spontaneous human adult stem cell transformation. Cancer Res. 2005; 65: 3035-9.
91. Hochedlinger K, Jaenisch R. Nuclear transplantation, embryonic stem cells, and the potential for cell therapy. N Engl J Med. 2003; 349: 275-86.
92. Dove A. Cell-based therapies go live. Nat Biotechnol. 2002; 20: 339-43.
93. Pomerantz J, Blau HM. Nuclear reprogramming: A key to stem cell function in rgenerative medicine. Nat Cell Biol. 2004; 6: 810-6.
94. Wagers AJ, Weissman IL. Plasticity of adult stem cells. Cell 2004; 116: 639-48.
95. Wilson ME, Scheel D, German MS. Gene expression cascades in pancreatic development. Mech Dev. 2003; 120: 65-80.
96. Yang X J, Kow LM, Funabashi T, Mobbs CHV. Hypothalamic glucose sensor. Similarities to and differences from pancreatic β-cell mechanisms. Diabetes 1999; 48: 1767-72.
97. + channel in rat brain. Brain Res. 1998; 814: 41-54.
98. 2+ changes in pancreatic beta cells and hypothalamic neurons. Pancreas 2005; 30: 227-32.
99. Liang Y, Matschinsky FM. Mechanisms of action of nonglucose insulin secretagogues. Annu Rev Nutr. 1994; 14: 59-81.
100. Vilsbøll, Holst JJ. Incretins, insulin secretion and type 2 diabetes. Diabetologia 2004; 47: 357-66.
101. Leclerc I, Rutter GA. AMP-activated protein kinase: A new β-cell glucose sensor? Regulation by amino acids and calcium ions. Diabetes 2004; 53: S67-74.
102. Rorsman P, Renström E. Insulin granule dynamics in pancreatic beta cells. Diabetologia 2003; 46: 1029-45.
103. Lang J. Molecular mechanisms and regulation of insulin exocytosis as a paradigm of endocrine secretion. Eur J Biochem. 1999; 259: 3-17.
104. Gerber SH, Südhof TC. Molecular determinants of regulated exocytosis. Diabetes. 2002; 51: S3-S11.
105. Melloul D, Marshak S, Cerasi E. Regulation of insulin gene transcription. Diabetologia 2002; 45: 309-26.
106. Hernández-Sánchez C, Rubio E, Serna J, de la Rosa EJ, de Pablo F. Unprocessed proinsulin promotes cell survival during neurulation in the chick embryo. Diabetes 2002; 51: 770-7.
107. Deltour L, Leduque P, Blume N, Madsen O, Dubois P, Jami J, Bucchini D. Differential expression of the two nonallelic proinsulin genes in the developing mouse embryo. Proc Nat Acad Sci USA 1993; 90: 527-31.